Dear [Full Name]

We are pleased to confirm your registration to view this Live Broadcast on a new treatment option for adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified, including DLBCL arising from follicular lymphoma, after at least 2 lines of systemic therapy.

Thank you for your participation!

• Date: 7/15/20

• Time: 12:30pm

• To view the broadcast, please click here.
  
  

For full Prescribing Information, Click Here

Faculty information

This Live Broadcast is sponsored by Karyopharm Therapeutics Inc.
© 2020 Karyopharm Therapeutics Inc. All rights reserved.
US-XPOV-05/20-00030